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Coagulase-negative staphylococci, once all identified as Staphylococcus epidermidis by clinical microbiologists, have recently been classified into 12 distinct species (5) . Representatives of many of these species have been documented as etiological agents in urinary tract infections (4, 9, 12, 13) , infections of indwelling intravenous catheters (2) and prosthetic devices (10) , as well as in bacteremia in cancer patients (3) . Because of this, clinical microbiologists are now faced with the integration into their daily laboratory practice of methods to identify these organisms.
Most accepted methods to identify coagulasenegative staphylococci, such as the simplified Kloos and Schleifer scheme (6) and the StaphIdent System (Analytab Products, Plainview, N.Y.) (8) , require the use of novobiocin susceptibility for a complete species level identification for a percentage of organisms tested. Previous investigators (6) have suggested two methods for testing novobiocin susceptibility for staphylococcal identifications. One method is to streak organisms onto P agar (PA) plates containing 1.6 ,ug of novobiocin per ml incorporated into the agar (6) . Organisms capable of growth on this medium are considered novobiocin resistant. The second technique entails estimating novobiocin susceptibility by using a 5-,ug novobiocin disk on an inoculated PA plate (6) . Strains that exhibit zones of inhibition of 5 mm or less from the edge of the disk (zone of inhibition .16 mm) are considered to be resistant to 1.6 ,ug of novobiocin per ml. Unfortunately, neither dehydrated PA nor prepared PA plates are commercially available. Also, clinical laboratories do not routinely utilize this medium for any other purpose. Therefore, clinical microbiologists wishing to identify coagulase-negative staphylococci must either prepare PA plates in their laboratories or test for novobiocin on a substitute agar contrary to the recommended technique (7).
The present investigation was undertaken to assess the utility of two media routinely used in clinical microbiology laboratories, Trypticase soy agar (BBL Microbiology Systems, Cockeysville, Md.) with 5% sheep blood (BA) and Mueller-Hinton agar (MH; BBL), for testing novobiocin susceptibility for the identification of coagulase-negative staphylococci. For this purpose, 10 representatives of each of seven susceptible coagulase-negative species and four resistant species were tested simultaneously on PA, BA, and MH and the results were compared. NOVOBIOCIN In the present study, results obtained for novobiocin susceptibilities on PA were compared with those obtained on both MH and BA. Representatives of seven susceptible species and four resistant species were tested. Results obtained with sensitive strains indicated significant differences between zone sizes obtained on PA and BA as well as between MH and BA. Zones of inhibition on BA were consistently smaller than those obtained on either PA or MH. Regardless of these differences, all susceptible strains tested yielded zones of inhibition >16 mm on all media tested. Therefore, all were correctly identified as susceptible by this method. One S. epidermidis strain gave a zone of inhibition of 16.2 mm when tested on BA, which might have been misinterpreted as resistant as a result of subjective differences in the measurement of individual zone diameters in this disk diffusion test. Forty resistant strains representing four different species were also tested. Interestingly, with these isolates, results on PA were significantly different than those on BA or MH, which did not differ from one another. Again, regardless of these differences, since the smallest zone size exhibited with a susceptible strain was 16.2 mm and the largest zone obtained with a resistant strain was 13.5 mm (difference of 2.7 mm), strains were correctly identified when using the 16-mm cutoff.
In summary, clinical laboratories identifying coagulase-negative staphylococci must often perform a novobiocin susceptibility test for a species level identification for a proportion of isolates tested. Results of the present investigation found both MH and BA to be satisfactory for this purpose as long as the accepted 16-mm cutoff is utilized as the interpretative standard to judge resistance.
